Moolec Science (MLEC) Capital Expenditures (2023 - 2024)
Moolec Science (MLEC) reported Capital Expenditures of -$4.1 million for Q4 2024, up 33.36% on a YoY basis from -$3.1 million in Q1 2024, and down 6734.62% sequentially from -$59738.0 in Q3 2024.
Moolec Science (MLEC) Capital Expenditures (2023 - 2024) Analysis & Trends
Moolec Science (MLEC) has 2 years of Capital Expenditures data on file, last reported at -$4.1 million in Q4 2024.
- For the quarter ending Q4 2024, Capital Expenditures rose 33.36% year-over-year to -$4.1 million; the trailing twelve-month figure through Dec 2024 stood at $5.9 million (changed N/A YoY), and the FY2025 full-year result was $5.7 million, down 43.12% from the prior year.
- Capital Expenditures eased to -$4.1 million in Q4 2024, from -$59738.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $11.5 million in Q2 2023 to a low of -$6.1 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -4.08 Mn |
| Dec 31, 2024 | -4.08 Mn |
| Sep 30, 2024 | -59,738.00 |
| Sep 30, 2024 | -59,738.00 |
| Jun 30, 2024 | 10.06 Mn |
| Jun 30, 2024 | 10.06 Mn |
| Mar 31, 2024 | -30,326.00 |
| Mar 31, 2024 | -30,326.00 |
| Dec 31, 2023 | -6.13 Mn |
| Dec 31, 2023 | -6.13 Mn |
| Sep 30, 2023 | -104,441.00 |
| Sep 30, 2023 | -104,441.00 |
| Jun 30, 2023 | 11.49 Mn |
| Jun 30, 2023 | 11.49 Mn |